Literature DB >> 21926465

TCR-dependent transformation of mature memory phenotype T cells in mice.

Xi Wang1, Miriam B F Werneck, Boris G Wilson, Hye-Jung Kim, Michael J Kluk, Christopher S Thom, Jonathan W Wischhusen, Julia A Evans, Jonathan L Jesneck, Phuong Nguyen, Courtney G Sansam, Harvey Cantor, Charles W M Roberts.   

Abstract

A fundamental goal in cancer research is the identification of the cell types and signaling pathways capable of initiating and sustaining tumor growth, as this has the potential to reveal therapeutic targets. Stem and progenitor cells have been implicated in the genesis of select lymphoid malignancies. However, the identity of the cells in which mature lymphoid neoplasms are initiated remains unclear. Here, we investigate the origin of peripheral T cell lymphomas using mice in which Snf5, a chromatin remodelling-complex subunit with tumor suppressor activity, could be conditionally inactivated in developing T cells. In this model of mature peripheral T cell lymphomas, the cell of origin was a mature CD44hiCD122loCD8⁺ T cell that resembled a subset of memory cells that has capacity for self-renewal and robust expansion, features shared with stem cells. Further analysis showed that Snf5 loss led to activation of a Myc-driven signaling network and stem cell transcriptional program. Finally, lymphomagenesis and lymphoma proliferation depended upon TCR signaling, establishing what we believe to be a new paradigm for lymphoid malignancy growth. These findings suggest that the self-renewal and robust proliferative capacities of memory T cells are associated with vulnerability to oncogenic transformation. Our findings further suggest that agents that impinge upon TCR signaling may represent an effective therapeutic modality for this class of lethal human cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926465      PMCID: PMC3195451          DOI: 10.1172/JCI37210

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

Review 1.  Cellular origin of human B-cell lymphomas.

Authors:  R Küppers; U Klein; M L Hansmann; K Rajewsky
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming.

Authors:  Nishant Singhal; Johannes Graumann; Guangming Wu; Marcos J Araúzo-Bravo; Dong Wook Han; Boris Greber; Luca Gentile; Matthias Mann; Hans R Schöler
Journal:  Cell       Date:  2010-06-11       Impact factor: 41.582

3.  Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.

Authors:  Stefanie Bug; Jan Dürig; Florian Oyen; Ludger Klein-Hitpass; Jose I Martin-Subero; Lana Harder; Michael Baudis; Norbert Arnold; Uwe Kordes; Ulrich Dührsen; Reinhard Schneppenheim; Reiner Siebert
Journal:  Cancer Genet Cytogenet       Date:  2009-07

4.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

5.  Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.

Authors:  Boris G Wilson; Xi Wang; Xiaohua Shen; Elizabeth S McKenna; Madeleine E Lemieux; Yoon-Jae Cho; Edward C Koellhoffer; Scott L Pomeroy; Stuart H Orkin; Charles W M Roberts
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

6.  ARID1A mutations in endometriosis-associated ovarian carcinomas.

Authors:  Kimberly C Wiegand; Sohrab P Shah; Osama M Al-Agha; Yongjun Zhao; Kane Tse; Thomas Zeng; Janine Senz; Melissa K McConechy; Michael S Anglesio; Steve E Kalloger; Winnie Yang; Alireza Heravi-Moussavi; Ryan Giuliany; Christine Chow; John Fee; Abdalnasser Zayed; Leah Prentice; Nataliya Melnyk; Gulisa Turashvili; Allen D Delaney; Jason Madore; Stephen Yip; Andrew W McPherson; Gavin Ha; Lynda Bell; Sian Fereday; Angela Tam; Laura Galletta; Patricia N Tonin; Diane Provencher; Dianne Miller; Steven J M Jones; Richard A Moore; Gregg B Morin; Arusha Oloumi; Niki Boyd; Samuel A Aparicio; Ie-Ming Shih; Anne-Marie Mes-Masson; David D Bowtell; Martin Hirst; Blake Gilks; Marco A Marra; David G Huntsman
Journal:  N Engl J Med       Date:  2010-09-08       Impact factor: 91.245

Review 7.  Molecular classification of T-cell lymphomas.

Authors:  Laurence de Leval; Bettina Bisig; Caroline Thielen; Jacques Boniver; Philippe Gaulard
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-23       Impact factor: 6.312

8.  The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.

Authors:  Konstanze Pechloff; Julian Holch; Uta Ferch; Marc Schweneker; Kristina Brunner; Markus Kremer; Tim Sparwasser; Leticia Quintanilla-Martinez; Ursula Zimber-Strobl; Berthold Streubel; Andreas Gewies; Christian Peschel; Jürgen Ruland
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

9.  Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.

Authors:  Xi Wang; Courtney G Sansam; Christopher S Thom; Daniel Metzger; Julia A Evans; Phuong T L Nguyen; Charles W M Roberts
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

10.  A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.

Authors:  Jonghwan Kim; Andrew J Woo; Jianlin Chu; Jonathan W Snow; Yuko Fujiwara; Chul Geun Kim; Alan B Cantor; Stuart H Orkin
Journal:  Cell       Date:  2010-10-15       Impact factor: 41.582

View more
  43 in total

1.  Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.

Authors:  Xiaofeng Wang; Jeffrey R Haswell; Charles W M Roberts
Journal:  Clin Cancer Res       Date:  2013-10-11       Impact factor: 12.531

2.  KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development.

Authors:  F J Martin; Y Xu; F Lohmann; D N Ciccone; T B Nicholson; J J Loureiro; T Chen; Q Huang
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

Review 3.  Memory NK cells: why do they reside in the liver?

Authors:  Xiaojun Jiang; Yonglin Chen; Hui Peng; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-08       Impact factor: 11.530

Review 4.  Control of Stimulus-Dependent Responses in Macrophages by SWI/SNF Chromatin Remodeling Complexes.

Authors:  Jovylyn Gatchalian; Jingwen Liao; Matthew B Maxwell; Diana C Hargreaves
Journal:  Trends Immunol       Date:  2020-01-09       Impact factor: 16.687

Review 5.  Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Cancer Genet       Date:  2014-04-13

6.  C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas.

Authors:  Rebeca Manso; Carmen Bellas; Paloma Martín-Acosta; Manuela Mollejo; Javier Menárguez; Federico Rojo; Pilar Llamas; Miguel A Piris; Socorro M Rodríguez-Pinilla
Journal:  Haematologica       Date:  2016-05-05       Impact factor: 9.941

Review 7.  New molecular insights into peripheral T cell lymphomas.

Authors:  Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

8.  PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.

Authors:  M R Spalinger; S Kasper; C Chassard; T Raselli; I Frey-Wagner; C Gottier; S Lang; K Atrott; S R Vavricka; F Mair; B Becher; C Lacroix; M Fried; G Rogler; M Scharl
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

Review 9.  A rationale to target the SWI/SNF complex for cancer therapy.

Authors:  Anja F Hohmann; Christopher R Vakoc
Journal:  Trends Genet       Date:  2014-06-03       Impact factor: 11.639

10.  Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.

Authors:  Boris G Wilson; Katherine C Helming; Xiaofeng Wang; Youngha Kim; Francisca Vazquez; Zainab Jagani; William C Hahn; Charles W M Roberts
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.